https://www.selleckchem.com/pr....oducts/CP-690550.htm
Synchronous colorectal cancer liver metastasis (CRLM) has been viewed as being more aggressive and having shorter survival than metachronous disease. Advances in CRLM management led us to examine differences in treatment characteristics of synchronous versus metachronous CRLM patients along with survival and recurrence. A retrospective review of hepatic resection for CRLM at a tertiary academic medical center was performed for two periods a historic cohort from 1992 to 2010 (n=121), and a modern cohort (n=179) from 2012 to 2018. Clini
Beğen
Yorum Yap
Paylaş
